title: Durable left ventricular assist device therapy in advanced heart failure: Patient selection and clinical outcomes.
abstract: The increasing adoption of left ventricular assist devices (LVADs) into clinical practice is related to a combination of engineering advances in pump technology and improvements in understanding the appropriate clinical use of these devices in the management of patients with advanced heart failure. This review intends to assist the clinician in identifying candidates for LVAD implantation, to examine long-term outcomes and provide an overview of the common complications related to use of these devices.
authors.affiliation: Center for Advanced Heart Disease, Brigham and Women's Hospital Heart and Vascular Center, Boston, MA, United States; Harvard Medical School, Boston, MA, United States; Division of Cardiovascular Medicine, Lahey Hospital and Medical Center, Burlington, MA, United States; Tufts University School of Medicine, Boston, MA, United States.
authors.forename: Sachin P
authors.initials: SP
authors.lastname: Shah
authors.affiliation: Center for Advanced Heart Disease, Brigham and Women's Hospital Heart and Vascular Center, Boston, MA, United States; Harvard Medical School, Boston, MA, United States. Electronic address: MMEHRA@BWH.HARVARD.EDU.
authors.forename: Mandeep R
authors.initials: MR
authors.lastname: Mehra
mesh_terms: D019468:Disease Management; D004867:Equipment Design; D006333:Heart Failure / Q000628:therapy*; D006353:Heart-Assist Devices; D006801:Humans; D018579:Patient Selection; D016896:Treatment Outcome
keywords: HeartMate XVE; INTERMACS; Novacor LVAD; REMATCH